Adynovi 250 IE (5 ml)

Adynovi 250 IE (5 ml) is a medicine authorised by Swissmedic under authorisation number 65953. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 September 2016 and the authorisation is valid without a time limit. ATC code B02BD02 places the medicine in the group Antihemorrhagics.

Dispensing category B
Authorisation number 65953
ATC B02BD02
Biotechnological medicines

Authorisation data
Authorisation number	65953
Name	Adynovi 250 IE (5 ml)
Full name	Adynovi 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holder	Takeda Pharma AG
Medicinal product code	Biotechnological medicines
Dispensing category	B · Prescription only
ATC code	B02BD02
First authorisation	06 September 2016
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Adynovi 250 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	06 September 2016
2	Adynovi 500 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	06 September 2016
3	Adynovi 1000 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	06 September 2016
4	Adynovi 2000 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	06 September 2016
5	Adynovi 250 IE (2 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	15 February 2018
6	Adynovi 500 IE (2 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	15 February 2018
7	Adynovi 1000 IE (2 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	15 February 2018
8	Adynovi 750 IE (2 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	29 September 2020
9	Adynovi 1500 IE (2 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	29 September 2020
10	Adynovi 3000 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	29 September 2020
11	Adynovi 750 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	29 September 2020
12	Adynovi 1500 IE (5 ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	29 September 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	1	Set	B02BD02	06.01.1.	B
5	1	Set	B02BD02	06.01.1.	B
2	1	Set	B02BD02	06.01.1.	B
6	1	Set	B02BD02	06.01.1.	B
3	1	Set	B02BD02	06.01.1.	B
7	1	Set	B02BD02	06.01.1.	B
4	1	Set	B02BD02	06.01.1.	B
8	1	Set	B02BD02	06.01.1.	B
10	1	Set	B02BD02	06.01.1.	B
12	1	Set	B02BD02	06.01.1.	B
14	1	Set	B02BD02	06.01.1.	B
15	1	Set	B02BD02	06.01.1.	B
16	1	Set	B02BD02	06.01.1.	B
17	1	Set	B02BD02	06.01.1.	B
18	1	Set	B02BD02	06.01.1.	B
19	1	Set	B02BD02	06.01.1.	B

Scroll the table sideways

Medicines in the same ATC group

Advate 250 IE (5 ml)Authorisation number 56352 · Takeda Pharma AG · ATC B02BD02B Afstyla 250 IEAuthorisation number 66030 · CSL Behring Lengnau AG · ATC B02BD02B Altuvoct 250 I.E.Authorisation number 69436 · Swedish Orphan Biovitrum AG · ATC B02BD02B Elocta 250 I.E.Authorisation number 65843 · Swedish Orphan Biovitrum AG · ATC B02BD02B Esperoct 500 IEAuthorisation number 67156 · Novo Nordisk Pharma AG · ATC B02BD02B Haemoctin 250 I.E.Authorisation number 60094 · Biotest (Schweiz) AG · ATC B02BD02B Jivi 1000 IEAuthorisation number 66882 · Bayer (Schweiz) AG · ATC B02BD02B Kovaltry 500 I.E.Authorisation number 65773 · Bayer (Schweiz) AG · ATC B02BD02B Nuwiq 250 IEAuthorisation number 65551 · Octapharma AG · ATC B02BD02B Octanate 250 I.E.Authorisation number 666 · Octapharma AG · ATC B02BD02B

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B Cuvitru 200 mg/mlAuthorisation number 65992 · ATC J06BA01B

Frequently asked questions

Is Adynovi 250 IE (5 ml) authorised in Switzerland?

Yes. Adynovi 250 IE (5 ml) is authorised by Swissmedic under authorisation number 65953, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Adynovi 250 IE (5 ml) have?

Adynovi 250 IE (5 ml) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Adynovi 250 IE (5 ml)?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.